All Drug LIST
| S No. | Date | Drug List | Price In USD | Action | ||
|---|---|---|---|---|---|---|
| 1 | Mar, 2023 | Humira Drug Sales & Forecast Humira (adalimumab) is a biologic therapy administered as a subcutaneous injection. It is approved to treat the following autoimmune diseases such as rheu... |
USD $15.00 | READ | BUY | Your Query |
| 2 | Apr, 2020 | Trulicity Drug Sales & Forecast Eli Lilly drug Trulicity, for the treatment of type 2 diabetes is approved in the United States and Europe in 2014 and Japan in 2015. MNG Tracker report t... |
USD $20.00 | READ | BUY | Your Query |
| 3 | Apr, 2020 | Humalog Drug Sales & Forecast Eli Lilly drug Humalog Mix75/25 and Humalog Mix50/50 are used to treat adults with diabetes for the control of high blood sugar. Its patent has expired in... |
USD $20.00 | READ | BUY | Your Query |
| 4 | Jun, 2020 | AdroGel Drug Sales AndroGel (testosterone gel) is a testosterone replacement therapy for males diagnosed with symptomatic low testosterone due to certain underlying conditio... |
USD $15.00 | READ | BUY | Your Query |
| 5 | Mar, 2020 | Lynparza Drug Sales & Forecast AstraZeneca drug Lynparza became the world’s ¬first approved PARP inhibitor in 2014. Initially indicated for the treatment of ovarian cancer, in 2017, ... |
USD $20.00 | READ | BUY | Your Query |
| 6 | Jun, 2020 | Creon Drug Sales & Forecast Creon (pancrelipase) is a pancreatic enzyme therapy for exocrine pancreatic insufficiency, a condition that occurs in patients with cystic fibrosis, chron... |
USD $15.00 | READ | BUY | Your Query |
| 7 | Jun, 2020 | Viekira Pak Drug Sales Viekira Pak is an all-oral, short-course, interferon-free therapy, with or without ribavirin, for the treatment of adult patients with genotype 1 chronic ... |
USD $15.00 | READ | BUY | Your Query |
| 8 | Mar, 2020 | Imfinzi Drug Sales & Forecast AstraZeneca drug Imfinzi is approved for lung and bladder cancer in 2017. Imfinzi, a human mAb that binds to PD-L1 and blocks the interaction of PD-L1 wit... |
USD $20.00 | READ | BUY | Your Query |
| 9 | Mar, 2020 | Brilinta/Brilique Drug Sales & Forecast Brilinta/Brilique (ticagrelor) is an oral antiplatelet for acute coronary syndromes (ACS). Brilinta/Brilique, one of AstraZeneca Growth Platforms, is an o... |
USD $20.00 | READ | BUY | Your Query |
| 10 | Mar, 2020 | Crestor Drug Sales & Forecast AstraZeneca drug Crestor is approved in more than 115 countries for the treatment of dyslipidaemia and hypercholesterolaemia. MNG Tracker report title “... |
USD $20.00 | READ | BUY | Your Query |
| 11 | Mar, 2020 | Tagrisso Drug Sales & Forecast AstraZeneca drug Tagrisso is approved for lung cancer in 2015. Tagrisso is a best-in-class, highly selective, irreversible inhibitor of the activating sen... |
USD $20.00 | READ | BUY | Your Query |
| 12 | Apr, 2020 | Alimta Drug Sales & Forecast Eli Lilly drug Alimta is used for the treatment of lung cancer. Its vitamin regimen patent plus pediatric exclusivity will expire in May 2022 in United St... |
USD $20.00 | READ | BUY | Your Query |
| 13 | Apr, 2020 | Forteo Drug Sales & Forecast Eli Lilly drug Forteo, for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture and for glucocorticoid-induced osteopor... |
USD $20.00 | READ | BUY | Your Query |
| 14 | Apr, 2020 | Basaglar Drug Sales & Forecast Eli Lilly drug Basaglar (insulin glargine injection), a long-acting human insulin analog for the treatment of diabetes launched in the United Sates in 201... |
USD $20.00 | READ | BUY | Your Query |
| 15 | Apr, 2020 | Atripla Drug Sales & Forecast GileadSciences drug Atripla is an oral formulation indicated as a complete regimen for the treatment of HIV-1 infection in certain patients. Atripla is a ... |
USD $15.00 | READ | BUY | Your Query |
| 16 | Apr, 2020 | Biktarvy Drug Sales & Forecast GileadSciences drug Biktarvy is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Biktarvy is a single tablet... |
USD $15.00 | READ | BUY | Your Query |
| 17 | Apr, 2020 | Odefsey Drug Sales & Forecast GileadSciences drug Odefsey is an oral formulation dosed once a day for the treatment of HIV-1 infection in certain patients. Odefsey is a single tablet r... |
USD $15.00 | READ | BUY | Your Query |
| 18 | Apr, 2020 | Vemlidy Drug Sales & Forecast GileadSciences drug Vemlidy is an oral formulation of TAF dosed once a day for the treatment of chronic hepatitis B virus (HBV) infection in adults with c... |
USD $15.00 | READ | BUY | Your Query |
| 19 | Apr, 2020 | Vosevi Drug Sales & Forecast GileadSciences drug Vosevi is an oral formulation of a once-daily, single tablet regimen of sofosbuvir, velpatasvir and voxilaprevir for the re-treatment ... |
USD $15.00 | READ | BUY | Your Query |
| 20 | Apr, 2020 | Yescarta Drug Sales & Forecast GileadSciences drug Yescarta (axicabtagene ciloleucel) is a (chimeric antigen receptor cell therapy) CAR-T for the treatment of adult patients with relaps... |
USD $15.00 | READ | BUY | Your Query |
| 21 | Apr, 2020 | Benlysta Drug Sales & Forecast GSK drug Benlysta is the world’s first and only biologic medicine specifically approved for adult and paediatric lupus to treat systemic lupus erythemat... |
USD $15.00 | READ | BUY | Your Query |
| 22 | Apr, 2020 | Bexsero Vaccine Sales & Forecast Since its launch in 2015, GSK Bexsero has become the industry-leading meningitis B vaccine. In the United States, where it is licensed for 10 to 25 year o... |
USD $15.00 | READ | BUY | Your Query |
| 23 | Apr, 2020 | Juluca Drug Sales & Forecast GSK received United States FDA approval for Juluca in 2017, a once-daily, single pill 2DR regimen for HIV. Juluca combines dolutegravir with rilpivirine (... |
USD $15.00 | READ | BUY | Your Query |
| 24 | Apr, 2020 | Shingrix Vaccine Sales & Forecast Shingrix marks a step change in the prevention of shingles, a painful and potentially serious illness. The vaccine addresses the age-related decline in im... |
USD $15.00 | READ | BUY | Your Query |
| 25 | Apr, 2020 | Zejula Drug Sales & Forecast Zejula, GlaxoSmithKline (GSK) oral PARP inhibitor, is approved in the United States and Europe for women with recurrent ovarian cancer. MNG Tracker report... |
USD $15.00 | READ | BUY | Your Query |
| 26 | Apr, 2020 | Darzalex Drug Sales & Forecast Johnson & Johnson drug Darzalex (daratumumab) is a prescription medicine used to treat a type of blood cancer called multiple myeloma. Darzalex is not che... |
USD $15.00 | READ | BUY | Your Query |
| 27 | Apr, 2020 | Erleada Drug Sales & Forecast Johnson & Johnson drug Erleada (apalutamide) is an androgen receptor (AR) inhibitor indicated for the treatment of patients with non-metastatic castration... |
USD $15.00 | READ | BUY | Your Query |
| 28 | Apr, 2020 | Imbruvica Drug Sales & Forecast Johnson & Johnson drug Imbruvica (ibrutinib) is an oral, once-daily medicine that works differently than chemotherapy as it blocks a protein called Bruton... |
USD $15.00 | READ | BUY | Your Query |
| 29 | Apr, 2020 | Stelara Drug Sales & Forecast Johnson & Johnson drug Stelara (ustekinumab), a treatment for adults and children with moderate to severe plaque psoriasis, for adults with active psoriat... |
USD $15.00 | READ | BUY | Your Query |
| 30 | Apr, 2020 | Bridion Drug Sales & Forecast Merck Bridion (sugammadex) Injection, a medication for the reversal of two types of neuromuscular blocking agents used during surgery. MNG Tracker report ... |
USD $15.00 | READ | BUY | Your Query |
| 31 | Apr, 2020 | Gardasil/Gardasil 9 Vaccine Sales & Forecast Merck Gardasil (Human Papillomavirus Quadrivalent [Types 6, 11, 16 and 18] Vaccine, Recombinant) and Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Re... |
USD $15.00 | READ | BUY | Your Query |
| 32 | Apr, 2020 | Keytruda Drug Sales & Forecast Merck drug Keytruda is used for the treatment of multiple types of cancer such as non-small-cell lung cancer (NSCLC), small-cell lung cancer (SCLC), head ... |
USD $15.00 | READ | BUY | Your Query |
| 33 | Apr, 2020 | ProQuad Vaccine Sales & Forecast Merck ProQuad is a pediatric combination vaccine to protect against measles, mumps, rubella and varicella in children 12 months through 12 years of age. U... |
USD $15.00 | READ | BUY | Your Query |
| 34 | Apr, 2020 | RotaTeq Vaccine Sales & Forecast RotaTeq is a vaccine indicated for the prevention of rotavirus gastroenteritis (diarrhoea and vomiting) caused by rotavirus infections types G1, G2, G3, G... |
USD $15.00 | READ | BUY | Your Query |
| 35 | Apr, 2020 | Varivax Vaccine Sales & Forecast Merck Varivax is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older. The Food and Drug ... |
USD $15.00 | READ | BUY | Your Query |
| 36 | Apr, 2020 | Chantix/Champix Drug Sales & Forecast Chantix (also known as Champix in the EU and other countries) was approved by the FDA in May 2006 as a prescription medication that, along with support, h... |
USD $15.00 | READ | BUY | Your Query |
| 37 | Apr, 2020 | Ibrance Drug Sales & Forecast Pfizer drug Ibrance is used for the treatment of adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (H... |
USD $15.00 | READ | BUY | Your Query |
| 38 | Apr, 2020 | Prevnar 13/Prevenar 13 Vaccine Sales & Forecast Prevnar 13/Prevenar 13 is Pfizer vaccines for prevention of pneumococcal disease. In 2014, the Advisory Committee on Immunization Practices (ACIP) voted t... |
USD $15.00 | READ | BUY | Your Query |
| 39 | May, 2020 | Xeljanz Drug Sales & Forecast Pfizer drug Xeljanz (tofacitinib) is approved in the United States for adult patients in three indications: moderately to severely active rheumatoid arthr... |
USD $15.00 | READ | BUY | Your Query |
| 40 | May, 2020 | Pfizer's Xtandi Drug Sales & Forecast Pfizer drug Xtandi is FDA-approved for the treatment of non-metastatic and metastatic castration-resistant prostate cancer as well as metastatic castratio... |
USD $15.00 | READ | BUY | Your Query |
| 41 | May, 2020 | Alecensa Drug Sales & Forecast Roche drug Alecensa is a highly selective, CNS active, oral medicine created at Chugai Kamakura Research Laboratories and is being developed for people wi... |
USD $15.00 | READ | BUY | Your Query |
| 42 | May, 2020 | Avastin Drug Sales & Forecast Roche drug Avastin is a prescription-only medicine that is a solution for intravenous infusion. It is a biologic antibody designed to specifically bind to... |
USD $15.00 | READ | BUY | Your Query |
| 43 | May, 2020 | Hemlibra Drug Sales & Forecast Roche drug Hemlibra is a prophylactic (preventative) treatment that can be administered by an injection of a ready-to-use solution under the skin (subcuta... |
USD $15.00 | READ | BUY | Your Query |
| 44 | May, 2020 | Herceptin Drug Sales & Forecast Roche drug Herceptin (trastuzumab) is a humanized monoclonal antibody, designed to target and block the function of HER2, a protein produced by a specific... |
USD $15.00 | READ | BUY | Your Query |
| 45 | May, 2020 | Kadcyla Drug Sales & Forecast Roche drug Kadcyla is an antibody-drug conjugate (ADC) engineered to deliver potent chemotherapy directly to HER2-positive cancer cells, potentially limit... |
USD $15.00 | READ | BUY | Your Query |
| 46 | May, 2020 | Ocrevus Drug Sales & Forecast Roche drug Ocrevus (ocrelizumab) is the first and only therapy approved for both relapsing forms of multiple sclerosis (RMS) (including clinically isolate... |
USD $15.00 | READ | BUY | Your Query |
| 47 | May, 2020 | Perjeta Drug Sales & Forecast Roche drug Perjeta is given intravenously and targets the HER2 protein. It was approved in 2012 for the treatment of patients with advanced or late-stage ... |
USD $15.00 | READ | BUY | Your Query |
| 48 | May, 2020 | Tecentriq Drug Sales & Forecast Roche drug Tecentriq is a cancer immunotherapy that has the potential to be used as a foundational combination partner with other immunotherapies, targete... |
USD $15.00 | READ | BUY | Your Query |
| 49 | May, 2020 | Aubagio Drug Sales & Forecast Sanofi drug Aubagio (teriflunomide), a small molecule immunomodulatory agent with anti-inflammatory properties, is a once-daily oral therapy. In 2017, San... |
USD $15.00 | READ | BUY | Your Query |
| 50 | May, 2020 | Cerezyme Drug Sales & Forecast Sanofi drug Cerezyme (imiglucerase) is an enzyme replacement therapy used to treat Gaucher disease, an inherited and potentially life-threatening LSD. It ... |
USD $15.00 | READ | BUY | Your Query |
| 51 | May, 2020 | Fabrazyme Drug Sales & Forecast Sanofi drug Fabrazyme (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease, an inherited and potentially life threatening LSD. F... |
USD $15.00 | READ | BUY | Your Query |
| 52 | May, 2020 | Dupixent Drug Sales & Forecast Sanofi drug Dupixent (dupilumab), a human monoclonal antibody, binds to the interleukin-4 receptor (IL-4R) and has been shown to specifically inhibit over... |
USD $15.00 | READ | BUY | Your Query |
| 53 | May, 2020 | Jevtana Drug Sales & Forecast Sanofi drug Jevtana (cabazitaxel), a chemotherapy drug and cytotoxic agent, is a semi-synthetic second-generation taxane which prevents many cancer cells ... |
USD $15.00 | READ | BUY | Your Query |
| 54 | May, 2020 | Lantus Drug Sales & Forecast Sanofi drug Lantus is a long-acting analog of human insulin, indicated for once-daily administration for the treatment of diabetes mellitus in adults, ado... |
USD $15.00 | READ | BUY | Your Query |
| 55 | Jun, 2020 | Lovenox/Clexane Drug Sales & Forecast Sanofi drug Lovenox/Clexane (enoxaparin sodium) is a low molecular weight heparin (LMWH) for use in the prophylaxis and treatment of venous thromboembolis... |
USD $15.00 | READ | BUY | Your Query |
| 56 | Jun, 2020 | Myozyme/Lumizyme Drug Sales & Forecast Sanofi drug Myozyme/Lumizyme (alglucosidase alfa, intravenous infusion) are recombinant forms of the same human enzyme and are enzyme replacement therapie... |
USD $15.00 | READ | BUY | Your Query |
| 57 | Jun, 2020 | Toujeo Drug Sales & Forecast Toujeo is a solution for injection that contains the active substance insulin glargine. It is long-acting human insulin analogue indicated to improve glyc... |
USD $15.00 | READ | BUY | Your Query |
| 58 | Jun, 2020 | Baraclude Drug Sales & Forecast BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th... |
USD $15.00 | READ | BUY | Your Query |
| 59 | Jun, 2020 | Eliquis Drug Sales & Forecast BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of ... |
USD $15.00 | READ | BUY | Your Query |
| 60 | Jun, 2020 | Empliciti Drug Sales & Forecast BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat... |
USD $15.00 | READ | BUY | Your Query |
| 61 | Jun, 2020 | Opdivo/Yervoy Drug Sales & Forecast Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti... |
USD $15.00 | READ | BUY | Your Query |
| 62 | Jun, 2020 | Orencia Drug Sales & Forecast BMS drug Orencia (abatacept), a biological product, is a fusion protein indicated for adult patients with moderately to severely active rheumatoid arthrit... |
USD $15.00 | READ | BUY | Your Query |
| 63 | Jun, 2020 | Sprycel Drug Sales & Forecast BMS drug Sprycel (dasatinib) is an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromos... |
USD $15.00 | READ | BUY | Your Query |
MNG Tracker is a market research company which offer market research reports and database subscription service. Continuous tracking on latest changes in the industry and predict about the emerging needs, challenges and opportunities, is the essential needs for the growth of the business. MNG Tracker is exists for that. MNG Tracker is steadily monitored on the latest happening in the industries, companies and regulatory policies around the world. MNG Tracker is all about market, research and data. We know our clients; who they are, what they see and what they do. MNG Tracker team is fully dedicated to achieve their needs and expectation.
Useful Links
Contact Us
COPYRIGHT © 2018 MNG Tracker. All Rights Reserved.